Philadelphia (PA): AACR Abstract nr. 5608 (2010). Sheikh NA, Petrylak D, De La Rosa CP, Stewart FP, Kuan LY, Whitmore JB, Trager JB, Poehlein CH, Frohlich MW, Urdal DL. Sipuleucel -T im mune parameters correlate with survival: an integrated analysis of randomized Phase 3 clinical trials in men with castrate -resistant prostate cancer (2012). Sportes C, Hakim FT, Memon SA, Zhang H, Chua KS, Brown MR, et al. Administration of rhIL -7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 205, 1701 –1714 (2008). Swainson L, Kinet S, Mongellaz C, Sourisseau M, Henriques T, Taylor N. IL -7-induced proliferation of recent thymic emigran ts requires activation of the PI3K pathway. Blood 109, 1034 –1042 (2007).